Decoy Therapeutics Inc. (DCOY)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-212.6%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0 | $1.84M | $5.23M | $3.47M | $1.95M | $1.27M | $1.01M |
| Cost of Revenue | — | — | — | — | — | — | — | $430.8K | $506.5K | $662.7K |
| Operating Income | -$12.61M | -$5.73M | -$12.89M | -$31.84M | -$12.81M | -$7.79M | -$8.27M | -$1.68M | -$34.73M | -$39.89M |
| Net Income | -$12.52M | -$5.58M | -$12.54M | -$31.61M | -$12.77M | -$7.35M | -$6.94M | -$1.67M | -$34.43M | -$39.49M |
| EPS (Diluted) | $-129.10 | $-69.54 | $-30.74 | $-14.88 | $-7.72 | $-0.50 | — | — | — | — |
| Total Assets | $11.06M | $3.02M | $6.59M | $14.65M | $40.83M | $24.93M | $13.89M | $6.61M | $34.99M | $63.21M |
| Total Liabilities | $5.17M | $1.51M | $1.30M | $4.27M | $2.11M | $2.77M | $3.31M | $7.88M | $5.89M | $3.90M |
| Shareholders' Equity | $5.89M | $1.51M | $5.29M | $10.38M | $38.72M | $22.16M | $10.58M | -$1.27M | -$2.90M | $59.32M |
| Cash & Equivalents | $10.71M | $2.43M | $5.90M | $12.11M | $29.21M | $11.12M | $3.74M | $3.23M | $19.19M | — |
| Operating Cash Flow | -$4.83M | -$4.53M | -$12.85M | -$17.60M | -$10.20M | -$10.31M | -$11.58M | $4.18M | -$27.72M | -$32.05M |
| Capital Expenditures | $577.0K | $0 | — | — | — | — | — | — | — | — |
| Shares Outstanding | 97.0K | 80.2K | 408.1K | 2.12M | 1.65M | 15.58M | — | — | — | — |